Emerging Issues in Antifungal Resistance
- PMID: 33131575
- DOI: 10.1016/j.idc.2020.05.003
Emerging Issues in Antifungal Resistance
Abstract
Invasive fungal diseases continue to cause substantial mortality in the enlarging immunocompromised population. It is fortunate that the field has moved past amphotericin B deoxycholate as the only available antifungal drug but despite new classes of antifungal agents both primary and secondary drug resistance in molds and yeasts abound. From the rise of multiple-drug-resistant Candida auris to the agrochemical selection of environmental azole-resistant Aspergillus fumigatus, it is and will be critical to understand antifungal drug resistance and both prevent and treat it with new strategies and agents.
Keywords: Antifungal agents; Drug resistance; Fungi; Invasive fungal disease.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
-
Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.Turk J Haematol. 2018 Mar 1;35(1):1-11. doi: 10.4274/tjh.2018.0007. Epub 2018 Feb 2. Turk J Haematol. 2018. PMID: 29391334 Free PMC article. Review.
-
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?Clin Microbiol Infect. 2020 Aug;26(8):1024-1033. doi: 10.1016/j.cmi.2020.02.017. Epub 2020 Feb 29. Clin Microbiol Infect. 2020. PMID: 32120042 Review.
-
Changes in the epidemiological landscape of invasive mould infections and disease.J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i5-i11. doi: 10.1093/jac/dkx028. J Antimicrob Chemother. 2017. PMID: 28355462
-
Combinatorial strategies for combating invasive fungal infections.Virulence. 2017 Feb 17;8(2):169-185. doi: 10.1080/21505594.2016.1196300. Epub 2016 Jun 7. Virulence. 2017. PMID: 27268286 Free PMC article. Review.
Cited by
-
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints.J Fungi (Basel). 2022 Jan 30;8(2):141. doi: 10.3390/jof8020141. J Fungi (Basel). 2022. PMID: 35205895 Free PMC article. Review.
-
Calcineurin Inhibitors Synergize with Manogepix to Kill Diverse Human Fungal Pathogens.J Fungi (Basel). 2022 Oct 19;8(10):1102. doi: 10.3390/jof8101102. J Fungi (Basel). 2022. PMID: 36294667 Free PMC article.
-
Will invasive fungal infections be The Last of Us? The importance of surveillance, public-health interventions, and antifungal stewardship.Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(8):787-790. doi: 10.1080/14787210.2023.2227790. Epub 2023 Jun 22. Expert Rev Anti Infect Ther. 2023. PMID: 37338176 Free PMC article. No abstract available.
-
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans.Pharm Res. 2022 Dec;39(12):3279-3291. doi: 10.1007/s11095-022-03407-7. Epub 2022 Oct 21. Pharm Res. 2022. PMID: 36271205 Free PMC article. Clinical Trial.
-
IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients.J Fungi (Basel). 2023 May 30;9(6):628. doi: 10.3390/jof9060628. J Fungi (Basel). 2023. PMID: 37367564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous